Bart Anthony Lutterbach, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2014 | 187 | 0.740 |
Why?
|
Gene Amplification | 3 | 2014 | 1062 | 0.620 |
Why?
|
Receptor, erbB-3 | 1 | 2008 | 142 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-met | 5 | 2013 | 578 | 0.290 |
Why?
|
Cell Proliferation | 4 | 2014 | 10472 | 0.270 |
Why?
|
Receptors, Growth Factor | 1 | 2007 | 334 | 0.270 |
Why?
|
Benzocycloheptenes | 2 | 2013 | 9 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 3 | 2007 | 4553 | 0.170 |
Why?
|
Stomach Neoplasms | 1 | 2008 | 1327 | 0.160 |
Why?
|
Cell Line, Tumor | 9 | 2020 | 16665 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6754 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2013 | 1659 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 5 | 2013 | 5522 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5163 | 0.110 |
Why?
|
Mice, Nude | 3 | 2014 | 3689 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2010 | 5171 | 0.100 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2013 | 261 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 647 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2014 | 3557 | 0.100 |
Why?
|
Cell Survival | 2 | 2014 | 5872 | 0.100 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.090 |
Why?
|
Pyrimidines | 2 | 2014 | 2933 | 0.090 |
Why?
|
Image Cytometry | 1 | 2008 | 54 | 0.080 |
Why?
|
RNA, Small Interfering | 2 | 2008 | 3504 | 0.080 |
Why?
|
Cell Growth Processes | 1 | 2008 | 400 | 0.070 |
Why?
|
Hepatocyte Growth Factor | 1 | 2008 | 270 | 0.070 |
Why?
|
Sulfonamides | 2 | 2013 | 1932 | 0.070 |
Why?
|
Dogs | 4 | 2013 | 3910 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2502 | 0.070 |
Why?
|
NF-kappa B | 1 | 2014 | 2500 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6382 | 0.060 |
Why?
|
Drug Discovery | 1 | 2013 | 1057 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2003 | 1581 | 0.060 |
Why?
|
Phosphorylation | 3 | 2011 | 8436 | 0.060 |
Why?
|
Smooth Muscle Myosins | 1 | 2003 | 2 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2028 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13019 | 0.050 |
Why?
|
Chromosome Inversion | 1 | 2003 | 127 | 0.050 |
Why?
|
Protein Sorting Signals | 1 | 2002 | 281 | 0.050 |
Why?
|
Apoptosis | 2 | 2008 | 9715 | 0.050 |
Why?
|
Myosin Heavy Chains | 1 | 2003 | 414 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2013 | 3701 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5662 | 0.050 |
Why?
|
Haplorhini | 2 | 2011 | 551 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2818 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 289 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2217 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2011 | 731 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3691 | 0.040 |
Why?
|
Mice | 6 | 2020 | 81045 | 0.040 |
Why?
|
Substrate Specificity | 2 | 2013 | 1802 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13655 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2003 | 3497 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1723 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2011 | 2014 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2003 | 9639 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2003 | 3020 | 0.030 |
Why?
|
Animals | 7 | 2020 | 168561 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1423 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3127 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2003 | 1884 | 0.030 |
Why?
|
Transcription Factors | 2 | 2003 | 12164 | 0.030 |
Why?
|
Subcellular Fractions | 2 | 2003 | 547 | 0.030 |
Why?
|
Models, Molecular | 2 | 2013 | 5454 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2011 | 3133 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2008 | 6347 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5249 | 0.020 |
Why?
|
Humans | 13 | 2020 | 742088 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2003 | 345 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2010 | 408 | 0.020 |
Why?
|
Signal Transduction | 2 | 2013 | 23387 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 8829 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2010 | 699 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2010 | 677 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3564 | 0.020 |
Why?
|
Neoplasms | 3 | 2013 | 21596 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 459 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2085 | 0.020 |
Why?
|
Automation | 1 | 2008 | 584 | 0.020 |
Why?
|
Rats | 2 | 2013 | 24265 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3847 | 0.020 |
Why?
|
Protein Binding | 2 | 2011 | 9387 | 0.020 |
Why?
|
Mutation | 4 | 2013 | 29717 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 4013 | 0.020 |
Why?
|
Transfection | 2 | 2003 | 5892 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8425 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 2 | 2003 | 3770 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2638 | 0.010 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2003 | 19 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2382 | 0.010 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2002 | 230 | 0.010 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 407 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3293 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18006 | 0.010 |
Why?
|
3T3 Cells | 1 | 2003 | 1101 | 0.010 |
Why?
|
Dimerization | 1 | 2003 | 893 | 0.010 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2002 | 462 | 0.010 |
Why?
|
Pyrazoles | 1 | 2011 | 1970 | 0.010 |
Why?
|
COS Cells | 1 | 2003 | 1160 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2002 | 585 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2008 | 2968 | 0.010 |
Why?
|
Immunoblotting | 1 | 2003 | 1683 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2003 | 729 | 0.010 |
Why?
|
Plasmids | 1 | 2003 | 2305 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2002 | 1758 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2002 | 1417 | 0.010 |
Why?
|
Protein Transport | 1 | 2002 | 1988 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5212 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12773 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 2699 | 0.010 |
Why?
|
Gene Deletion | 1 | 2003 | 2751 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6313 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19223 | 0.010 |
Why?
|
Binding Sites | 1 | 2002 | 6115 | 0.010 |
Why?
|
Female | 4 | 2013 | 379592 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9581 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 8925 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7721 | 0.010 |
Why?
|
Aged | 1 | 2020 | 162944 | 0.000 |
Why?
|
Male | 1 | 2020 | 349538 | 0.000 |
Why?
|